Twincretin drug Tirzepatide shows unmatched efficacy in weight loss and diabetes management

FHS
July 15, 2024
4:30 am

Tirzepatide, a novel twincretin drug, significantly improves weight loss and glycemic control in obese and type 2 diabetes patients, outperforming traditional treatments in clinical trials.

Funding from Breast Cancer Now supports research into new drugs for secondary breast cancer in the bone

Researchers are testing new combinations of drugs to treat breast cancer that’s spread to the bone, thanks to funding from Breast Cancer Now.

August 25, 2023

Study reveals link between impulsivity, aggression, and internet gaming addiction

The association between impulsivity and aggression as risk factors for Internet Gaming Disorder.

February 16, 2024

Digital Blueprint for Healthcare: A Roadmap for Transformation

Rupert Colbourne, Chief Technology Officer at Orbus Software The digital arms race continues in healthcare as the industry struggles to tackle fundamental issues, including systemic

October 17, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.